Belgium vs Slovenia: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
Slovenia
0
in 2020
Belgium rank
10th
Slovenia rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Slovenia
How they compare
Belgium currently reports 0.6 against 0 in Slovenia, a difference of 0.6.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Slovenia ahead.
Belgium ranks 10th and Slovenia ranks 13th of 52 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and Slovenia in 1.
Head to head by decade
| Decade | Belgium | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0 | 0.266 | 0.266 | Slovenia |
| 2020s | 0.6 | 0 | 0.6 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Slovenia?
- Belgium, at 0.6 against 0 in Slovenia as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Slovenia?
- 0.6, with Belgium ahead.
- How many years of comparable data are there for Belgium and Slovenia?
- 10 years are reported by both, from 2009 to 2020.
- How do Belgium and Slovenia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and Slovenia ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.